Aktive Positionen von Anabel Chan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMMUNOGEN, INC. | Investor Relations Kontakt | - | - |
Karriereverlauf von Anabel Chan
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Investor Relations Contact | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Anabel Chan
- Erfahrung
